//
Shukui Qin
Zhendong Chen
Ying Liu
Jianping Xiong
Zhenggang Ren
Zhiqiang Meng
ShanZhi Gu
Linna Wang
Jianjun Zou
Jinling Hospital, Nanjing, China
Department of Pediatrics, The Second Hospital of Anhui Medical University, Hefei, China
Department of Medical Oncology, Zhejiang Cancer Hospital, Zhejiang, China
Department of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang, China
Department of Pathology, Zhong Shan Hospital, Fudan University, Shanghai, China
Department of Traditional Chinese Medicine, Fudan University Shanghai Cancer Center, Shanghai, China
Department of Interventional Radiology, Hunan Cancer Hospital, Changsha, China
Jiangsu Hengrui Medicine Co., Ltd., Shanghai, China
China
Jiangsu Hengrui Phar
Oncology (ONC)
N/A
Circulating tumor cells
Fluorouracil
Adrucil injection
Camrelizumab
Gemcitabine
Oxaliplatin
leucovorin
FOLFOX 4
N/A
Single Arm
Multicenteric
II
NCT03092895
N/A
Final